Xiaolin Yang

1.4k total citations
81 papers, 1.0k citations indexed

About

Xiaolin Yang is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Xiaolin Yang has authored 81 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Genetics and 10 papers in Oncology. Recurrent topics in Xiaolin Yang's work include Neuroscience and Neuropharmacology Research (6 papers), Epilepsy research and treatment (5 papers) and Pharmacological Effects of Natural Compounds (4 papers). Xiaolin Yang is often cited by papers focused on Neuroscience and Neuropharmacology Research (6 papers), Epilepsy research and treatment (5 papers) and Pharmacological Effects of Natural Compounds (4 papers). Xiaolin Yang collaborates with scholars based in China, United States and Sweden. Xiaolin Yang's co-authors include Ulf J. Eriksson, Zhonglin Yang, Lisa Borg, L.A.H. Borg, Meixia Zhang, Fei Li, Chunfeng Zhang, Yihui Deng, Chunyan Sun and Jesse Li‐Ling and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Brain.

In The Last Decade

Xiaolin Yang

73 papers receiving 986 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaolin Yang China 17 440 162 117 115 113 81 1.0k
Alessandra Gamberucci Italy 27 807 1.8× 94 0.6× 103 0.9× 68 0.6× 33 0.3× 63 1.7k
Zhen Ren China 24 596 1.4× 67 0.4× 127 1.1× 68 0.6× 30 0.3× 59 1.4k
Huiyun Liang United States 15 940 2.1× 123 0.8× 100 0.9× 43 0.4× 64 0.6× 31 1.7k
Shyi‐Wu Wang Taiwan 19 245 0.6× 109 0.7× 71 0.6× 37 0.3× 31 0.3× 43 953
Anna Stachurska Poland 19 677 1.5× 65 0.4× 60 0.5× 180 1.6× 25 0.2× 51 1.2k
Himanshu Goel Australia 21 495 1.1× 289 1.8× 46 0.4× 254 2.2× 74 0.7× 104 1.3k
Patricia K. Tithof United States 17 328 0.7× 78 0.5× 82 0.7× 50 0.4× 21 0.2× 22 1.1k
Yoshimitsu Kiriyama Japan 16 584 1.3× 156 1.0× 188 1.6× 36 0.3× 52 0.5× 30 1.1k
Kang‐Min Lee South Korea 19 479 1.1× 95 0.6× 74 0.6× 95 0.8× 20 0.2× 60 1.3k
Wanda M. Krajewska Poland 23 661 1.5× 272 1.7× 242 2.1× 65 0.6× 15 0.1× 92 1.6k

Countries citing papers authored by Xiaolin Yang

Since Specialization
Citations

This map shows the geographic impact of Xiaolin Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolin Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolin Yang more than expected).

Fields of papers citing papers by Xiaolin Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolin Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolin Yang. The network helps show where Xiaolin Yang may publish in the future.

Co-authorship network of co-authors of Xiaolin Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolin Yang. A scholar is included among the top collaborators of Xiaolin Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolin Yang. Xiaolin Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Xiaojie, Xiaolin Yang, Kai-Yu Liao, et al.. (2024). Rydberg-Atom Terahertz Heterodyne Receiver with Ultrahigh Spectral Resolution. Chinese Physics Letters. 41(8). 84201–84201. 3 indexed citations
3.
Li, Wenjing, Yi Zhang, & Xiaolin Yang. (2024). Riemann-Hilbert approach and multi-soliton solutions of nonlocal Newell-type long wave-short wave equation. Physica Scripta. 99(7). 75246–75246.
4.
Lin, Chu, Xiaoling Cai, Fang Lv, et al.. (2024). The opportunities and challenges of the disease-modifying immunotherapy for type 1 diabetes: A systematic review and meta-analysis. Pharmacological Research. 203. 107157–107157. 7 indexed citations
5.
Yang, Xiaolin & Qing Huang. (2024). Narrative Thinking of Healthcare Providers in Medical Cases and Its Implications for Modern Medical Education. SHILAP Revista de lepidopterología. 7(4). 271–280. 1 indexed citations
6.
Shu, Yun, Zhifeng Wu, Xiaolin Yang, et al.. (2023). The burden of epilepsy in the People’s Republic of China from 1990 to 2019: epidemiological trends and comparison with the global burden of epilepsy. Frontiers in Neurology. 14. 1303531–1303531. 17 indexed citations
7.
Yang, Xiaolin, et al.. (2023). Imaging diagnostic features of intracranial primary extranodal Rosai-Dorfman disease: Two case reports and literature review. SHILAP Revista de lepidopterología. 18(6). 2165–2171. 1 indexed citations
8.
Wang, Zhongke, Yang Li, Shujing Li, et al.. (2023). Predictive model for epileptogenic tubers from all tubers in patients with tuberous sclerosis complex based on 18F-FDG PET: an 8-year single-centre study. BMC Medicine. 21(1). 500–500. 6 indexed citations
10.
Shen, Kai‐Feng, Zhifeng Wu, Ke‐Fu Wu, et al.. (2022). Fibroblast growth factor 13 is involved in the pathogenesis of temporal lobe epilepsy. Cerebral Cortex. 32(23). 5259–5272. 7 indexed citations
11.
Wang, Zhongke, Yang Li, Shu-Jing Li, et al.. (2022). Downregulated formyl peptide receptor 2 expression in the epileptogenic foci of patients with focal cortical dysplasia type IIb and tuberous sclerosis complex. Immunity Inflammation and Disease. 10(11). e706–e706. 5 indexed citations
13.
Li, Miaomiao, et al.. (2022). Development and validation of a risk prediction model for breast cancer-related lymphedema in postoperative patients with breast cancer. European Journal of Oncology Nursing. 63. 102258–102258. 4 indexed citations
14.
Shen, Kai‐Feng, Xiaolin Yang, Guolong Liu, et al.. (2021). The role of voltage-gated chloride channels in the epileptogenesis of temporal lobe epilepsy. EBioMedicine. 70. 103537–103537. 14 indexed citations
15.
16.
He, Jiaojiang, Yujia Wei, Kai‐Feng Shen, et al.. (2020). Decreased expression of Rev-Erbα in the epileptic foci of temporal lobe epilepsy and activation of Rev-Erbα have anti-inflammatory and neuroprotective effects in the pilocarpine model. Journal of Neuroinflammation. 17(1). 43–43. 34 indexed citations
17.
Li, Fei, Xiaolin Yang, Yanan Yang, et al.. (2015). Phospholipid complex as an approach for bioavailability enhancement of echinacoside. Drug Development and Industrial Pharmacy. 41(11). 1777–1784. 35 indexed citations
18.
Li, Fei, Xiaolin Yang, Ya‐Nan Yang, et al.. (2013). Antiosteoporotic activity of echinacoside in ovariectomized rats. Phytomedicine. 20(6). 549–557. 77 indexed citations
19.
Xu, Zhengmin, et al.. (2011). Performance of two hearing screening protocols in NICU in Shanghai. International Journal of Pediatric Otorhinolaryngology. 75(10). 1225–1229. 17 indexed citations
20.
Zhang, Meixia, Hongliang Zhang, Chunyan Sun, et al.. (2008). Targeted constitutive activation of signal transducer and activator of transcription 3 in human hepatocellular carcinoma cells by cucurbitacin B. Cancer Chemotherapy and Pharmacology. 63(4). 635–642. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026